Bumper Offer - Urjas oil Just @ Rs. 1
Arvast Gold is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Arvast Gold is used -
Severe
Moderate
Mild
Common
Is the use of Arvast Gold safe for pregnant women?
Arvast Gold shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Arvast Gold safe during breastfeeding?
Taking Arvast Gold may lead to serious side effects if you are breastfeeding. Arvast Gold should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Arvast Gold on the Kidneys?
Arvast Gold can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Arvast Gold on the Liver?
Arvast Gold does not damage the liver.
What is the effect of Arvast Gold on the Heart?
There may be an adverse effect on the heart after taking Arvast Gold. If you observe any side effects on your body then stop taking this drug. Restart this medicine only if your doctor advises you to do so.
Arvast Gold should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Arvast Gold unless your doctor advises you to do so -
Is this Arvast Gold habit forming or addictive?
Arvast Gold is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Arvast Gold since it will not make you feel sleepy.
Is it safe?
Yes, but take Arvast Gold only as per medical advice.
Is it able to treat mental disorders?
No, the use of Arvast Gold in mental disorders is not effective.
Interaction between Food and Arvast Gold
There isn't any research available on the side effects of taking Arvast Gold with food.
Interaction between Alcohol and Arvast Gold
Due to lack of research, there is no information about the side effects of taking Arvast Gold with alcohol.
Yes, Arvast Gold is safe to use, if taken in prescribed amount for a specified time as advised by the doctor. However, few side effects are observed at regular doses such as confusion, dizziness, joint pain, and muscle pain. Do not hesitate to inform your doctor if you are facing any of the above.
No, Arvast Gold should not be discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine.
Arvast Gold works by inhibiting an enzyme (HMG-CoA reductase) which is responsible for cholesterol synthesis in our body, its inhibition results in increased levels of HDL (good cholesterol) and decreased levels of LDL (bad cholesterol) which lowers the risk of developing heart disease and helps in preventing strokes
Arvast Gold is a brand name of rosuvastatin which belongs to the class of drugs known as statins (dyslipidemic agents). It is a prescription drug that is used for the treatment of mixed dyslipidemia (high levels of lipids in the blood), hypercholesterolemia (high cholesterol levels), and hypertriglyceridemia.
Yes, use of Arvast Gold may cause memory loss in the patients who are taking it. It is a rare side effect of this drug. However, if you experience severe memory loss after taking this drug, then do not hesitate to inform your doctor immediately.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
